Ellis I - Search Results

1

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S; METABRIC Group; Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C, Aparicio S. Curtis C, et al. Among authors: ellis i. Nature. 2012 Apr 18;486(7403):346-52. doi: 10.1038/nature10983. Nature. 2012. PMID: 22522925 Free PMC article.

2

P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.

Dixon AR, Bell J, Ellis IO, Elston CW, Blamey RW. Dixon AR, et al. Among authors: ellis io. Br J Cancer. 1992 Sep;66(3):537-41. doi: 10.1038/bjc.1992.309. Br J Cancer. 1992. PMID: 1355661 Free PMC article.

3

The Nottingham Prognostic Index in primary breast cancer.

Galea MH, Blamey RW, Elston CE, Ellis IO. Galea MH, et al. Among authors: ellis io. Breast Cancer Res Treat. 1992;22(3):207-19. doi: 10.1007/BF01840834. Breast Cancer Res Treat. 1992. PMID: 1391987

4

Cellular effects of tamoxifen in primary breast cancer.

Robertson JF, Ellis IO, Nicholson RI, Robins A, Bell J, Blamey RW. Robertson JF, et al. Among authors: ellis io. Breast Cancer Res Treat. 1992 Jan;20(2):117-23. doi: 10.1007/BF01834641. Breast Cancer Res Treat. 1992. PMID: 1554887

5

Node negative breast cancer prognosis and DNA ploidy.

Galea MH, Ellis IO, Elston CW, Blamey RW. Galea MH, et al. Among authors: ellis io. Br J Surg. 1992 Feb;79(2):181. doi: 10.1002/bjs.1800790232. Br J Surg. 1992. PMID: 1555075 No abstract available.

6

Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.

Sacks NP, Robertson JF, Ellis IO, Nicholson RI, Crocker J, Blamey RW. Sacks NP, et al. Among authors: ellis io. Eur J Surg Oncol. 1992 Apr;18(2):98-102. Eur J Surg Oncol. 1992. PMID: 1582518

7

Ki67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival.

Locker AP, Birrell K, Bell JA, Nicholson RI, Elston CW, Blamey RW, Ellis IO. Locker AP, et al. Among authors: ellis io. Eur J Surg Oncol. 1992 Jun;18(3):224-9. Eur J Surg Oncol. 1992. PMID: 1607032

8

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up.

Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Ellis IO, et al. Histopathology. 1992 Jun;20(6):479-89. doi: 10.1111/j.1365-2559.1992.tb01032.x. Histopathology. 1992. PMID: 1607149

9

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.

Dixon AR, Ellis IO, Elston CW, Blamey RW. Dixon AR, et al. Among authors: ellis io. Br J Cancer. 1991 Apr;63(4):634-5. doi: 10.1038/bjc.1991.145. Br J Cancer. 1991. PMID: 1850613 Free PMC article.

10

Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival.

Griffith CD, Ellis IO, Bell J, Burns K, Blamey RW. Griffith CD, et al. Among authors: ellis io. J R Coll Surg Edinb. 1990 Oct;35(5):289-92. J R Coll Surg Edinb. 1990. PMID: 2283605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,055 results

Search Page